FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study



Status:Recruiting
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:3/8/2019
Start Date:June 1, 2018
End Date:July 2022
Contact:Nicole Glowacki, MS
Email:nicole.glowacki@abbott.com
Phone:651-756-3432

Use our guide to learn which trials are right for you!

FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of Ventricular Tachycardia (LESS-VT) Study

This clinical investigation is intended to demonstrate the safety and effectiveness of
ventricular ablation therapy using the FlexAbility Sensor Enabled Ablation Catheter in
patients with drug-refractory monomorphic ventricular tachycardia in whom ventricular
tachycardia recurs despite antiarrhythmic drug therapy or when antiarrhythmic drugs are not
tolerated or desired.


Inclusion Criteria:

- Structural heart disease (ischemic or non-ischemic) with one of the following:

- Confirmed diagnosis via echocardiography and/or cardiac MRI, or

- Left ventricular ejection fraction (EF) <40% (documented within the last 6 months
via TTE, or

- Arrhythmogenic RV cardiomyopathy/dysplasia (per 2010 ARVC/D Task Force
Criteria).27

- At least one documented episode of sustained MMVT by either EGM or ECG in the 6 months
prior to enrollment

- Implanted with a market released ICD or CRT-D for at least 30 days prior to index
ablation procedure

- Refractory (i.e. not effective, not tolerated or not desired) to at least one
anti-arrhythmic medication (either amiodarone or sotalol) for treatment of MMVT

- At least 18 years of age

- Informed of the nature of the study, agreed to its provisions and has provided written
informed consent as approved by the Institutional Review Board/Ethics Committee
(IRB/EC) of the respective clinical study site.

- Able and willing to comply with all study requirements

Exclusion Criteria:

- Implanted with a subcutaneous ICD

- Implanted with a ventricular assist device (VAD) (e.g. TandemHeart)

- Currently receiving support, or anticipated to receive support prior to the index
ablation procedure, via extracorporeal membrane oxygenation (ECMO)

- Presence of intracardiac thrombus verified via computer tomography (CT), magnetic
resonance imaging (MRI), transesophageal echocardiogram (TEE), or transthoracic
echocardiogram (TTE) within 48 hours prior to the index ablation procedure or
intra-procedure intracardiac echocardiography (ICE)

o For subjects with a history of AF, this verification must be done via TEE

- ST elevation myocardial infarction (MI) within 60 days prior to index ablation
procedure

- Previous cardiac surgery (e.g. ventriculotomy, atriotomy, coronary artery bypass
graft), within 60 days prior to index ablation procedure

- Percutaneous coronary intervention (PCI) within 30 days prior to index ablation
procedure

- Idiopathic VT

- Incessant VT (continuous sustained VT that promptly recurs despite repeated
intervention for termination over ≥3 hours) necessitating immediate treatment or
requiring hemodynamic support prior to the ablation procedure

- VT/VF thought to be from channelopathies

- Reversible cause of VT

- Severe aortic stenosis or flail mitral valve

- Mechanical mitral and aortic valve

- History of stroke with modified Rankin scale > 3 (See Appendix C)

- Unstable angina

- Chronic NYHA Class IV heart failure

- Ejection fraction < 15%

- Thrombocytopenia (defined as platelet count <80,000) or coagulopathy

- Contraindication to systemic anticoagulation (i.e. heparin, warfarin, or a direct
thrombin inhibitor)

- Women who are pregnant or nursing

- Active uncontrolled infection

- Other anatomic or co morbid conditions that, in the investigator's opinion, could
limit the patient's ability to participate in the study or to comply with follow up
requirements, or impact the scientific soundness of the study results

- Enrolled in an investigational study evaluating another device or drug that would
confound the results of this study

- Have a life expectancy of less than 12 months due to any condition.
We found this trial at
15
sites
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials
5801 South Ellis Avenue
Chicago, Illinois 60637
 773.702.1234
University of Chicago One of the world's premier academic and research institutions, the University of...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
3400 Spruce St
Philadelphia, Pennsylvania 19104
 (215) 662-4000
Phone: 215-662-6801
Hospital of the University of Pennsylvania The Hospital of the University of Pennsylvania (HUP) is...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
1364 Clifton Rd NE
Atlanta, Georgia 30322
(404) 712-2000
Phone: 770-757-6455
Emory University Hospital As the largest health care system in Georgia and the only health...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
12605 East 16th Avenue
Aurora, Colorado 80045
720-848-0000
Phone: 720-848-6510
University of Colorado Hospital, Site Top medical professionals, superior medicine and progressive change make University...
?
mi
from
Aurora, CO
Click here to add this to my saved trials
Austin, Texas 78705
Phone: 512-807-3150
?
mi
from
Austin, TX
Click here to add this to my saved trials
Baltimore, Maryland 21287
Phone: 410-903-1182
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Birmingham, Alabama 35294
Phone: 205-934-2525
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
171 Ashley Avenue
Charleston, South Carolina 29425
843-792-1414
Phone: 843-876-4760
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
?
mi
from
Charleston, SC
Click here to add this to my saved trials
Hollywood, Florida 33021
Phone: 954-981-3331
?
mi
from
Hollywood, FL
Click here to add this to my saved trials
Los Angeles, California 90095
Phone: 310-206-2235
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Los Angeles, California 90033
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Minneapolis, Minnesota 55417
Phone: 612-467-3662
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Prague, Central Bohemia 14021
?
mi
from
Prague,
Click here to add this to my saved trials
Raleigh, North Carolina
Phone: 919-724-2281
?
mi
from
Raleigh, NC
Click here to add this to my saved trials